AlexandraDrakakiMD
Oncology • Santa Monica, CAGenitourinary Oncology, Hematologic Oncology
Clinical Instructor, UCLA
Dr. Drakaki is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
2020 Santa Monica Blvd
Ste 600
Santa Monica, CA 90404Phone+1 310-829-5471Fax+1 310-829-6192
Education & Training
Beth Israel Deaconess Medical CenterFellowship, Hematology and Medical Oncology, 2010 - 2013
Tufts Medical CenterResidency, Internal Medicine, 2007 - 2010
University of Crete School of Health SciencesClass of 2006
Certifications & Licensure
CA State Medical License 2013 - 2025
MA State Medical License Active through 2013- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- FELLOWSHIP/ GI ASCO MERITT AWARD ASCO, 2013
Clinical Trials
- A Study of Ramucirumab (LY3009806) Plus Docetaxel in Participants With Urothelial Cancer Start of enrollment: 2015 Jul 13
Publications & Presentations
PubMed
- 1470 citationsAtezolizumab as first-line treatment in cisplatin-ineligible patients with locally advanced and metastatic urothelial carcinoma: a single-arm, multicentre, phase 2 trial.Arjun Vasant Balar, Matthew D. Galsky, Jonathan E. Rosenberg, Thomas Powles, Daniel P. Petrylak
Lancet. 2017-01-07 - 12 citationsTreatment Rechallenge With Immune Checkpoint Inhibitors in Advanced Urothelial Carcinoma.Dimitrios Makrakis, Dimitra Rafailia Bakaloudi, Rafee Talukder, Genevieve Ihsiu Lin, Leonidas N Diamantopoulos
Clinical Genitourinary Cancer. 2023-04-01 - 15 citationsSafety and efficacy of immune checkpoint inhibitors in advanced penile cancer: report from the Global Society of Rare Genitourinary Tumors.Talal El Zarif, Amin H Nassar, Gregory R Pond, Tony Zibo Zhuang, Viraj Master
Journal of the National Cancer Institute. 2023-12-06
Authored Content
- Association of Baseline Systemic Corticosteroid Use with Overall Survival and Time to Next Treatment in Patients Receiving Immune Checkpoint Inhibitor Therapy in Real-World US Oncology Practice for Advanced Non-Small Cell Lung Cancer, Melanoma, or Urothelial CarcinomaJune 2020
Press Mentions
New Imaging Technique Accurately Detects Aggressive Kidney Cancer, Claims StudyOctober 21st, 2024- New Imaging Technique Accurately Detects Aggressive Kidney CancerOctober 3rd, 2024
- Adjuvant Therapy for Improved Disease-Free Survival for Patients with Muscle-Invasive Urothelial Carcinoma Following Radical Surgery - Checkmate 274 - Petros GrivasMarch 28th, 2021
- Join now to see all
Grant Support
- Role of mir9 in liver oncogenesisUCLAPresent
Research History
- PhD/Identification of microRNA signature in liver oncogenesis2015 - Present
Other Languages
- Greek
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
